Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Example Chemotherapy Medication Request — Doxorubicin

Raw json | Download

{
  "resourceType" : "MedicationRequest",
  "id" : "ChemotherapyMedicationRequestExample",
  "meta" : {
    "profile" : [
      🔗 "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-chemotherapy-medication-request"
    ]
  },
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Doxorubicin 60 mg/m² IV short infusion, day 1 of cycle 1 for breast cancer (AC regimen)</p></div>"
  },
  "extension" : [
    {
      "url" : "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-cycle-day-start-extension",
      "valueInteger" : 1
    },
    {
      "url" : "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-cycle-day-end-extension",
      "valueInteger" : 1
    },
    {
      "url" : "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-clinical-category-extension",
      "valueCode" : "CHEMOTHERAPY"
    }
  ],
  "identifier" : [
    {
      "system" : "https://nshr-uat.sha.go.ke/fhir/med-request-id",
      "value" : "MR-2026-00301"
    }
  ],
  "status" : "active",
  "intent" : "order",
  "category" : [
    {
      "coding" : [
        {
          "system" : "http://terminology.hl7.org/CodeSystem/medicationrequest-category",
          "code" : "inpatient",
          "display" : "Inpatient"
        }
      ]
    }
  ],
  "medicationCodeableConcept" : {
    "coding" : [
      {
        "system" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/generic-products-cs",
        "code" : "DOXORUBICIN",
        "display" : "Doxorubicin"
      }
    ]
  },
  "subject" : {
    🔗 "reference" : "Patient/example-patient"
  },
  "authoredOn" : "2026-01-10",
  "requester" : {
    🔗 "reference" : "Practitioner/example-practitioner"
  },
  "reasonReference" : [
    {
      🔗 "reference" : "Condition/example-condition"
    }
  ],
  "basedOn" : [
    {
      🔗 "reference" : "CarePlan/example-careplan"
    }
  ],
  "dosageInstruction" : [
    {
      "route" : {
        "coding" : [
          {
            "system" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/route-of-administration-cs",
            "code" : "RT10036",
            "display" : "Intravenous"
          }
        ]
      },
      "doseAndRate" : [
        {
          "doseQuantity" : {
            "value" : 60,
            "unit" : "mg/m2",
            "system" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/unit-of-measure-cs",
            "code" : "MG-PER-M2"
          }
        }
      ]
    }
  ]
}